缺血性卒中后急性症状性发作类型与死亡及癫痫风险的关联及更新预后模型
这项队列研究纳入9个三级转诊中心2002至2019年数据,推导队列4552例影像确诊缺血性卒中成人,急性症状性发作226例(5%),其中8例(0.2%)为癫痫持续状态。癫痫持续状态者10年死亡率为79%,短程发作者为30%,无发作者为11%;10年癫痫风险分别为81%、40%和13%。更新的SeLECT 2.0模型可反映卒中后癫痫高风险。
要点
- 急性症状性癫痫持续状态者10年死亡率为79%,短程发作者为30%,无发作者为11%。
- 急性症状性癫痫持续状态者10年癫痫风险为81%,短程发作者为40%,无发作者为13%。
- SeLECT 2.0预后模型可反映卒中后癫痫高风险,可能有助于抗癫痫药物续用及随访决策。
核心结论
- 卒中后急性症状性发作表现为癫痫持续状态者,死亡率和癫痫风险高于短程急性症状性发作或无发作者。
- SeLECT 2.0预后模型充分反映了高风险病例的癫痫风险,可能有助于抗癫痫药物续用及随访方法和频率的决策。
研究设计与样本
- 队列研究分析2002至2019年9个三级转诊中心的数据。
- 推导队列包括7个队列和2项病例对照研究的成人,均为神经影像确诊的缺血性卒中且无癫痫发作史。
- 重复验证在3个独立队列中进行,纳入神经影像确诊缺血性卒中后急性症状性癫痫持续状态的成人。
- 最终数据分析于2022年7月进行。
主要发现
- 推导队列共纳入4552例成人,其中男性2547例(56%),女性2005例(44%),中位年龄73岁(IQR 62-81)。
- 急性症状性发作发生于226例(5%),其中8例(0.2%)表现为癫痫持续状态。
- 急性症状性癫痫持续状态者10年死亡率为79%,短程急性症状性发作者为30%,无发作者为11%。
- 急性症状性癫痫持续状态者10年癫痫风险为81%,短程急性症状性发作者为40%,无发作者为13%。
- 重复验证队列包括39例缺血性卒中后急性症状性癫痫持续状态者(女性24例,中位年龄78岁),10年死亡风险和癫痫风险分别为76%和88%。
关键数值与推荐
- 急性症状性发作定义为缺血性卒中后7天内发生的发作。
- 癫痫定义为卒中后超过7天出现至少1次非诱发性发作。
- 更新后的SeLECT 2.0预后模型将急性症状性发作类型作为协变量。
临床怎么用
- 作者认为SeLECT 2.0预后模型可能有助于抗癫痫药物续用及随访方法和频率的决策。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Acute symptomatic seizures occurring within 7 days after ischemic stroke may be associated with an increased mortality and risk of epilepsy. It is unknown whether the type of acute symptomatic seizure influences this risk. OBJECTIVE: To compare mortality and risk of epilepsy following different types of acute symptomatic seizures. DESIGN, SETTING, AND PARTICIPANTS: This cohort study analyzed data acquired from 2002 to 2019 from 9 tertiary referral centers. The derivation cohort included adults from 7 cohorts and 2 case-control studies with neuroimaging-confirmed ischemic stroke and without a history of seizures. Replication in 3 separate cohorts included adults with acute symptomatic status epilepticus after neuroimaging-confirmed ischemic stroke. The final data analysis was performed in July 2022. EXPOSURES: Type of acute symptomatic seizure. MAIN OUTCOMES AND MEASURES: All-cause mortality and epilepsy (at least 1 unprovoked seizure presenting >7 days after stroke). RESULTS: A total of 4552 adults were included in the derivation cohort (2547 male participants [56%]; 2005 female [44%]; median age, 73 years [IQR, 62-81]). Acute symptomatic seizures occurred in 226 individuals (5%), of whom 8 (0.2%) presented with status epilepticus. In patients with acute symptomatic status epilepticus, 10-year mortality was 79% compared with 30% in those with short acute symptomatic seizures and 11% in those without seizures. The 10-year risk of epilepsy in stroke survivors with acute symptomatic status epilepticus was 81%, compared with 40% in survivors with short acute symptomatic seizures and 13% in survivors without seizures. In a replication cohort of 39 individuals with acute symptomatic status epilepticus after ischemic stroke (24 female; median age, 78 years), the 10-year risk of mortality and epilepsy was 76% and 88%, respectively. We updated a previously described prognostic model (SeLECT 2.0) with the type of acute symptomatic seizures as a covariate. SeLECT 2.0 successfully captured cases at high risk of poststroke epilepsy. CONCLUSIONS AND RELEVANCE: In this study, individuals with stroke and acute symptomatic seizures presenting as status epilepticus had a higher mortality and risk of epilepsy compared with those with short acute symptomatic seizures or no seizures. The SeLECT 2.0 prognostic model adequately reflected the risk of epilepsy in high-risk cases and may inform decisions on the continuation of antiseizure medication treatment and the methods and frequency of follow-up.
引用
- Sinka L, Abraira L, Imbach LL, et al. Association of Mortality and Risk of Epilepsy With Type of Acute Symptomatic Seizure After Ischemic Stroke and an Updated Prognostic Model. JAMA Neurol. 2023. PMID: 37036702. doi:10.1001/jamaneurol.2023.0611
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。